Latest Acinetobacter Stories
OKLAHOMA CITY, May 20, 2015 /PRNewswire/ -- Synereca Pharmaceuticals, Inc.
Funding to Support Development of New Treatments for Drug-Resistant Gram-Negative Bacterial Infections OKLAHOMA CITY, Sept. 16, 2014 /PRNewswire/ -- Synereca Pharmaceutics, Inc.
ALBANY, New York, September 8, 2014 /PRNewswire/ -- According to a new market report published by Transparency Market Research "Pipeline Analysis of Hospital Acquired Pneumonia
Carbapenems Are Increasingly Being Deployed as Frontline Therapies, According to Findings from Decision Resources Group BURLINGTON, Mass., May 15, 2014 /PRNewswire/ -- Decision Resources Group
A new study finds that infectious pathogen levels are higher in water obtained from hospital water taps with aerators than water from deeper in the plumbing system.
RnRMarketResearch.com adds “EpiCast Report Gram-Negative Bacterial Urinary Tract Infection – Epidemiology Forecast to 2022” to its store.
A new type of antibiotic called a PPMO, which works by blocking genes essential for bacterial reproduction, successfully killed a multidrug-resistant germ common to health care settings.
Acinetobacter baumannii is a species of pathogenic bacteria that is resistant to most antibiotics. Some think the disease is killing tens of thousands of U.S. hospital patients each year due to its resistance to drug treatment. It can cause severe pneumonia and infections of the urinary tract, bloodstream, and other parts of the body. It forms opportunistic infections including reports of attacking wounded soldiers and is sometimes abbreviated as MDRAB. It is the most relevant human...
- The analysis of literature, focusing on the words and grammar to the exclusion of context or literary merit.